Academic Journal
Cannabinoids in integumentary wound care : a systematic review of emerging preclinical and clinical evidence
| Τίτλος: | Cannabinoids in integumentary wound care : a systematic review of emerging preclinical and clinical evidence |
|---|---|
| Συγγραφείς: | Niyangoda, D., Muayad, M., Tesfaye, W., Bushell, M., Ahmad, D., Samarawickrema, I., Sinclair, Justin (R19074), Kebriti, S., Maida, V., Thomas, J. |
| Στοιχεία εκδότη: | Switzerland, MDPI |
| Έτος έκδοσης: | 2024 |
| Συλλογή: | University of Western Sydney (UWS): Research Direct |
| Θεματικοί όροι: | XXXXXX - Unknown |
| Περιγραφή: | This systematic review critically evaluates preclinical and clinical data on the antibacterial and wound healing properties of cannabinoids in integument wounds. Comprehensive searches were conducted across multiple databases, including CINAHL, Cochrane library, Medline, Embase, PubMed, Web of Science, and LILACS, encompassing records up to May 22, 2024. Eighteen studies met the inclusion criteria. Eleven were animal studies, predominantly utilizing murine models (n = 10) and one equine model, involving 437 animals. The seven human studies ranged from case reports to randomized controlled trials, encompassing 92 participants aged six months to ninety years, with sample sizes varying from 1 to 69 patients. The studies examined the effects of various cannabinoid formulations, including combinations with other plant extracts, crude extracts, and purified and synthetic cannabis-based medications administered topically, intraperitoneally, orally, or sublingually. Four animal and three human studies reported complete wound closure. Hemp fruit oil extract, cannabidiol (CBD), and GP1a resulted in complete wound closure in twenty-three (range: 5–84) days with a healing rate of 66–86% within ten days in animal studies. One human study documented a wound healing rate of 3.3 cm2 over 30 days, while three studies on chronic, non-healing wounds reported an average healing time of 54 (21–150) days for 17 patients by oral oils with tetrahydrocannabinol (THC) and CBD and topical gels with THC, CBD, and terpenes. CBD and tetrahydrocannabidiol demonstrated significant potential in reducing bacterial loads in murine models. However, further high-quality research is imperative to fully elucidate the therapeutic potential of cannabinoids in the treatment of bacterial skin infections and wounds. Additionally, it is crucial to delineate the impact of medicinal cannabis on the various phases of wound healing. This study was registered in PROSPERO (CRD42021255413). |
| Τύπος εγγράφου: | article in journal/newspaper |
| Περιγραφή αρχείου: | |
| Γλώσσα: | English |
| Relation: | Pharmaceutics--1999-4923-- Vol. 16 Issue. 8 No. 1081 pp: - |
| DOI: | 10.3390/pharmaceutics16081081 |
| Διαθεσιμότητα: | https://doi.org/10.3390/pharmaceutics16081081 https://hdl.handle.net/1959.7/uws:78908 |
| Rights: | © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/) |
| Αριθμός Καταχώρησης: | edsbas.1CE61D29 |
| Βάση Δεδομένων: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://doi.org/10.3390/pharmaceutics16081081# Name: EDS - BASE (ns324271) Category: fullText Text: View record from BASE |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.1CE61D29 RelevancyScore: 945 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 944.983581542969 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cannabinoids in integumentary wound care : a systematic review of emerging preclinical and clinical evidence – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Niyangoda%2C+D%2E%22">Niyangoda, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Muayad%2C+M%2E%22">Muayad, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Tesfaye%2C+W%2E%22">Tesfaye, W.</searchLink><br /><searchLink fieldCode="AR" term="%22Bushell%2C+M%2E%22">Bushell, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Ahmad%2C+D%2E%22">Ahmad, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Samarawickrema%2C+I%2E%22">Samarawickrema, I.</searchLink><br /><searchLink fieldCode="AR" term="%22Sinclair%2C+Justin+%28R19074%29%22">Sinclair, Justin (R19074)</searchLink><br /><searchLink fieldCode="AR" term="%22Kebriti%2C+S%2E%22">Kebriti, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Maida%2C+V%2E%22">Maida, V.</searchLink><br /><searchLink fieldCode="AR" term="%22Thomas%2C+J%2E%22">Thomas, J.</searchLink> – Name: Publisher Label: Publisher Information Group: PubInfo Data: Switzerland, MDPI – Name: DatePubCY Label: Publication Year Group: Date Data: 2024 – Name: Subset Label: Collection Group: HoldingsInfo Data: University of Western Sydney (UWS): Research Direct – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22XXXXXX+-+Unknown%22">XXXXXX - Unknown</searchLink> – Name: Abstract Label: Description Group: Ab Data: This systematic review critically evaluates preclinical and clinical data on the antibacterial and wound healing properties of cannabinoids in integument wounds. Comprehensive searches were conducted across multiple databases, including CINAHL, Cochrane library, Medline, Embase, PubMed, Web of Science, and LILACS, encompassing records up to May 22, 2024. Eighteen studies met the inclusion criteria. Eleven were animal studies, predominantly utilizing murine models (n = 10) and one equine model, involving 437 animals. The seven human studies ranged from case reports to randomized controlled trials, encompassing 92 participants aged six months to ninety years, with sample sizes varying from 1 to 69 patients. The studies examined the effects of various cannabinoid formulations, including combinations with other plant extracts, crude extracts, and purified and synthetic cannabis-based medications administered topically, intraperitoneally, orally, or sublingually. Four animal and three human studies reported complete wound closure. Hemp fruit oil extract, cannabidiol (CBD), and GP1a resulted in complete wound closure in twenty-three (range: 5–84) days with a healing rate of 66–86% within ten days in animal studies. One human study documented a wound healing rate of 3.3 cm2 over 30 days, while three studies on chronic, non-healing wounds reported an average healing time of 54 (21–150) days for 17 patients by oral oils with tetrahydrocannabinol (THC) and CBD and topical gels with THC, CBD, and terpenes. CBD and tetrahydrocannabidiol demonstrated significant potential in reducing bacterial loads in murine models. However, further high-quality research is imperative to fully elucidate the therapeutic potential of cannabinoids in the treatment of bacterial skin infections and wounds. Additionally, it is crucial to delineate the impact of medicinal cannabis on the various phases of wound healing. This study was registered in PROSPERO (CRD42021255413). – Name: TypeDocument Label: Document Type Group: TypDoc Data: article in journal/newspaper – Name: Format Label: File Description Group: SrcInfo Data: print – Name: Language Label: Language Group: Lang Data: English – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: Pharmaceutics--1999-4923-- Vol. 16 Issue. 8 No. 1081 pp: - – Name: DOI Label: DOI Group: ID Data: 10.3390/pharmaceutics16081081 – Name: URL Label: Availability Group: URL Data: https://doi.org/10.3390/pharmaceutics16081081<br />https://hdl.handle.net/1959.7/uws:78908 – Name: Copyright Label: Rights Group: Cpyrght Data: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/) – Name: AN Label: Accession Number Group: ID Data: edsbas.1CE61D29 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.1CE61D29 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/pharmaceutics16081081 Languages: – Text: English Subjects: – SubjectFull: XXXXXX - Unknown Type: general Titles: – TitleFull: Cannabinoids in integumentary wound care : a systematic review of emerging preclinical and clinical evidence Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Niyangoda, D. – PersonEntity: Name: NameFull: Muayad, M. – PersonEntity: Name: NameFull: Tesfaye, W. – PersonEntity: Name: NameFull: Bushell, M. – PersonEntity: Name: NameFull: Ahmad, D. – PersonEntity: Name: NameFull: Samarawickrema, I. – PersonEntity: Name: NameFull: Sinclair, Justin (R19074) – PersonEntity: Name: NameFull: Kebriti, S. – PersonEntity: Name: NameFull: Maida, V. – PersonEntity: Name: NameFull: Thomas, J. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2024 Identifiers: – Type: issn-locals Value: edsbas – Type: issn-locals Value: edsbas.oa |
| ResultId | 1 |